Trial Outcomes & Findings for Recovery and Analgesia After Surgery for Gynecological Cancer (NCT NCT02026687)

NCT ID: NCT02026687

Last Updated: 2019-09-24

Results Overview

From day of surgery (Day 0) until discharge after surgery

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

80 participants

Primary outcome timeframe

Participants will be followed for the duration of hospital stay, an expected average of 4 days

Results posted on

2019-09-24

Participant Flow

Participant milestones

Participant milestones
Measure
Epidural Analgesia
The epidural anesthesia is applied at a low thoracic level, primarily Th10-Th11. A bolus dose of fentanyl together with a continuous infusion of bupivacain 2.5 mg/ml, fentanyl 1.8 µg/ml and epinephrine 2.5 µg/ml is used during surgery. Infusion rate is chosen by the attending anesthetist. Postoperatively the epidural anesthesia is continued until the morning of the third postoperative day using bupivacain 1 mg/ml, fentanyl 2 µg/ml and epinephrine 2µg/ml. Infusion rate is set by the responsible physician, maximum rate is 10 ml/hour. Epidural
Intrathecal Analgesia
The patient is given one intrathecal dose of plain bupivacaine (Marcain® spinal) 5 mg/ml, 15 mg together with morphine (Morphine Special®) 0,4 mg/ml, 0.2 mg and clonidine (Catapresan®) 150 µg/ml, 75 µg. The intrathecal mixture is given through a lumbal puncture at level L2/3, L3/4 or L4/5 before the induction of general anesthesia. Intrathecal
Overall Study
STARTED
40
40
Overall Study
COMPLETED
39
38
Overall Study
NOT COMPLETED
1
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Epidural Analgesia
n=40 Participants
The epidural anesthesia is applied at a low thoracic level, primarily Th10-Th11. A bolus dose of fentanyl together with a continuous infusion of bupivacain 2.5 mg/ml, fentanyl 1.8 µg/ml and epinephrine 2.5 µg/ml is used during surgery. Infusion rate is chosen by the attending anesthetist. Postoperatively the epidural anesthesia is continued until the morning of the third postoperative day using bupivacain 1 mg/ml, fentanyl 2 µg/ml and epinephrine 2µg/ml. Infusion rate is set by the responsible physician, maximum rate is 10 ml/hour. Epidural
Intrathecal Analgesia
n=40 Participants
The patient is given one intrathecal dose of plain bupivacaine (Marcain® spinal) 5 mg/ml, 15 mg together with morphine (Morphine Special®) 0,4 mg/ml, 0.2 mg and clonidine (Catapresan®) 150 µg/ml, 75 µg. The intrathecal mixture is given through a lumbal puncture at level L2/3, L3/4 or L4/5 before the induction of general anesthesia. Intrathecal
Total
n=80 Participants
Total of all reporting groups
Age, Continuous
59.0 years
STANDARD_DEVIATION 14.5 • n=40 Participants
58.5 years
STANDARD_DEVIATION 8.5 • n=40 Participants
58.7 years
STANDARD_DEVIATION 8.9 • n=80 Participants
Sex: Female, Male
Female
40 Participants
n=40 Participants
40 Participants
n=40 Participants
80 Participants
n=80 Participants
Sex: Female, Male
Male
0 Participants
n=40 Participants
0 Participants
n=40 Participants
0 Participants
n=80 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Sweden
40 participants
n=40 Participants
40 participants
n=40 Participants
80 participants
n=80 Participants

PRIMARY outcome

Timeframe: Participants will be followed for the duration of hospital stay, an expected average of 4 days

From day of surgery (Day 0) until discharge after surgery

Outcome measures

Outcome measures
Measure
Epidural
n=40 Participants
The EDA was performed by a low thoracic puncture. The epidural infusion included a bolus dose of fentanyl 50-100 µg and a bolus from a mixture of bupivacaine 2.4 mg/ml, adrenalin 2.4 µg/ml and fentanyl 1.8 µg/ml. For the EDA group, a continuous epidural infusion of a mixture of bupivacain 1 mg/ml + adrenalin 2µg/ml + fentanyl 2 µg/ml including the possibility of additional patient-controlled bolus doses was started postoperatively at the postoperative care unit and continued until the morning of the third postoperative day. The infusion rate, normally 4-8 ml/h, and bolus doses, normally 2 ml, were decided on by the responsible physician. The patients also had oral paracetamol 1330 mg three times daily, starting on the day of surgery. Oral oxycodone 10-20 mg twice daily and diclofenac 50 mg three times daily were added in the morning of the third postoperative day before removal of the epidural catheter according to the
Spinal
n=40 Participants
The spinal group had an intrathecal combination of a single dose isobar bupivacaine 15 mg, morphine 0.2 mg and clonidine 75µg. The women in the ITM group received oral paracetamol 1330 mg and diclofenac 50 mg, both three times daily started on the day of surgery. Oxycodone 10-20 mg twice daily was added on the first postoperative day.
Length of Stay
4.3 days
Interval 3.5 to 5.2
3.3 days
Interval 3.1 to 4.8

SECONDARY outcome

Timeframe: Preoperatively and until 6 weeks after surgery

The questionnaire Short Form with 36 questions "SF-36" will be used preoperatively and at 6 weeks after surgery. The SF-36 consists of eight scaled subscores (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental Health) and two Component summary scores (physical Component summary scoer, mental component summary score). A score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Outcome measures

Outcome measures
Measure
Epidural
n=40 Participants
The EDA was performed by a low thoracic puncture. The epidural infusion included a bolus dose of fentanyl 50-100 µg and a bolus from a mixture of bupivacaine 2.4 mg/ml, adrenalin 2.4 µg/ml and fentanyl 1.8 µg/ml. For the EDA group, a continuous epidural infusion of a mixture of bupivacain 1 mg/ml + adrenalin 2µg/ml + fentanyl 2 µg/ml including the possibility of additional patient-controlled bolus doses was started postoperatively at the postoperative care unit and continued until the morning of the third postoperative day. The infusion rate, normally 4-8 ml/h, and bolus doses, normally 2 ml, were decided on by the responsible physician. The patients also had oral paracetamol 1330 mg three times daily, starting on the day of surgery. Oral oxycodone 10-20 mg twice daily and diclofenac 50 mg three times daily were added in the morning of the third postoperative day before removal of the epidural catheter according to the
Spinal
n=40 Participants
The spinal group had an intrathecal combination of a single dose isobar bupivacaine 15 mg, morphine 0.2 mg and clonidine 75µg. The women in the ITM group received oral paracetamol 1330 mg and diclofenac 50 mg, both three times daily started on the day of surgery. Oxycodone 10-20 mg twice daily was added on the first postoperative day.
Change in Quality of Life
SF-36 Physical component summary score baseline
44 units on a scale
Interval 34.0 to 53.0
45 units on a scale
Interval 34.0 to 53.0
Change in Quality of Life
SF-36 Physical component summary score day 42
39 units on a scale
Interval 34.0 to 44.0
38 units on a scale
Interval 35.0 to 42.0
Change in Quality of Life
SF-36 mental component summary score baseline
46 units on a scale
Interval 35.0 to 52.0
46 units on a scale
Interval 35.0 to 51.0
Change in Quality of Life
SF-36 mental component summary score day 42
49 units on a scale
Interval 34.0 to 53.0
51 units on a scale
Interval 39.0 to 55.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Day of surgery (day 0) until 6 weeks after surgery

Pain at rest will be assessed using a numeric rating scale from 0 (no pain) to 10 (worst imaginable pain). Pain is documented on the day of surgery (day 0), 3 times daily postoperative day 1, 2, 3, 4, 5, 6, 7, 14, 21, 28, 35 and 42. Scale: NRS Minimum value:0 Maximum value: 10. Higher scores indicate worse outcome.

Outcome measures

Outcome measures
Measure
Epidural
n=40 Participants
The EDA was performed by a low thoracic puncture. The epidural infusion included a bolus dose of fentanyl 50-100 µg and a bolus from a mixture of bupivacaine 2.4 mg/ml, adrenalin 2.4 µg/ml and fentanyl 1.8 µg/ml. For the EDA group, a continuous epidural infusion of a mixture of bupivacain 1 mg/ml + adrenalin 2µg/ml + fentanyl 2 µg/ml including the possibility of additional patient-controlled bolus doses was started postoperatively at the postoperative care unit and continued until the morning of the third postoperative day. The infusion rate, normally 4-8 ml/h, and bolus doses, normally 2 ml, were decided on by the responsible physician. The patients also had oral paracetamol 1330 mg three times daily, starting on the day of surgery. Oral oxycodone 10-20 mg twice daily and diclofenac 50 mg three times daily were added in the morning of the third postoperative day before removal of the epidural catheter according to the
Spinal
n=40 Participants
The spinal group had an intrathecal combination of a single dose isobar bupivacaine 15 mg, morphine 0.2 mg and clonidine 75µg. The women in the ITM group received oral paracetamol 1330 mg and diclofenac 50 mg, both three times daily started on the day of surgery. Oxycodone 10-20 mg twice daily was added on the first postoperative day.
Change in Pain
Pain at rest Day 35
0.3 units on a scale
Interval 0.1 to 0.5
0.3 units on a scale
Interval 0.0 to 0.6
Change in Pain
Pain at rest Day 0
1.5 units on a scale
Interval 0.8 to 2.1
2.7 units on a scale
Interval 2.0 to 3.4
Change in Pain
Pain at rest Day 1
1.6 units on a scale
Interval 1.0 to 2.3
3.2 units on a scale
Interval 2.6 to 3.8
Change in Pain
Pain at rest Day 2
1.5 units on a scale
Interval 0.9 to 2.1
2.1 units on a scale
Interval 1.5 to 2.7
Change in Pain
Pain at rest Day 3
2.9 units on a scale
Interval 2.2 to 3.6
1.4 units on a scale
Interval 0.8 to 2.1
Change in Pain
Pain at rest Day 4
1.4 units on a scale
Interval 0.8 to 1.9
1.6 units on a scale
Interval 1.1 to 2.2
Change in Pain
Pain at rest Day 5
1.1 units on a scale
Interval 0.7 to 1.6
1.2 units on a scale
Interval 0.7 to 1.7
Change in Pain
Pain at rest Day 6
1.0 units on a scale
Interval 0.5 to 1.4
1.1 units on a scale
Interval 0.7 to 1.5
Change in Pain
Pain at rest Day 7
1.1 units on a scale
Interval 0.5 to 1.6
1.0 units on a scale
Interval 0.6 to 1.3
Change in Pain
Pain at rest Day 14
0.8 units on a scale
Interval 0.4 to 1.2
0.7 units on a scale
Interval 0.2 to 1.2
Change in Pain
Pain at rest Day 21
0.5 units on a scale
Interval 0.1 to 0.8
0.3 units on a scale
Interval 0.0 to 0.6
Change in Pain
Pain at rest Day 28
0.2 units on a scale
Interval 0.0 to 0.3
0.2 units on a scale
Interval 0.0 to 0.4
Change in Pain
Pain at rest Day 42
0.5 units on a scale
Interval 0.0 to 0.9
0.1 units on a scale
Interval 0.0 to 0.2

Adverse Events

Epidural

Serious events: 2 serious events
Other events: 17 other events
Deaths: 0 deaths

Spinal

Serious events: 7 serious events
Other events: 14 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Epidural
n=40 participants at risk
The EDA was performed by a low thoracic puncture. The epidural infusion included a bolus dose of fentanyl 50-100 µg and a bolus from a mixture of bupivacaine 2.4 mg/ml, adrenalin 2.4 µg/ml and fentanyl 1.8 µg/ml. For the EDA group, a continuous epidural infusion of a mixture of bupivacain 1 mg/ml + adrenalin 2µg/ml + fentanyl 2 µg/ml including the possibility of additional patient-controlled bolus doses was started postoperatively at the postoperative care unit and continued until the morning of the third postoperative day. The infusion rate, normally 4-8 ml/h, and bolus doses, normally 2 ml, were decided on by the responsible physician. The patients also had oral paracetamol 1330 mg three times daily, starting on the day of surgery. Oral oxycodone 10-20 mg twice daily and diclofenac 50 mg three times daily were added in the morning of the third postoperative day before removal of the epidural catheter according to the
Spinal
n=40 participants at risk
The spinal group had an intrathecal combination of a single dose isobar bupivacaine 15 mg, morphine 0.2 mg and clonidine 75µg. The women in the ITM group received oral paracetamol 1330 mg and diclofenac 50 mg, both three times daily started on the day of surgery. Oxycodone 10-20 mg twice daily was added on the first postoperative day.
Surgical and medical procedures
Intensive care treatment
2.5%
1/40 • Number of events 1
2.5%
1/40 • Number of events 1
Surgical and medical procedures
Surgical intervention
2.5%
1/40 • Number of events 1
15.0%
6/40 • Number of events 6

Other adverse events

Other adverse events
Measure
Epidural
n=40 participants at risk
The EDA was performed by a low thoracic puncture. The epidural infusion included a bolus dose of fentanyl 50-100 µg and a bolus from a mixture of bupivacaine 2.4 mg/ml, adrenalin 2.4 µg/ml and fentanyl 1.8 µg/ml. For the EDA group, a continuous epidural infusion of a mixture of bupivacain 1 mg/ml + adrenalin 2µg/ml + fentanyl 2 µg/ml including the possibility of additional patient-controlled bolus doses was started postoperatively at the postoperative care unit and continued until the morning of the third postoperative day. The infusion rate, normally 4-8 ml/h, and bolus doses, normally 2 ml, were decided on by the responsible physician. The patients also had oral paracetamol 1330 mg three times daily, starting on the day of surgery. Oral oxycodone 10-20 mg twice daily and diclofenac 50 mg three times daily were added in the morning of the third postoperative day before removal of the epidural catheter according to the
Spinal
n=40 participants at risk
The spinal group had an intrathecal combination of a single dose isobar bupivacaine 15 mg, morphine 0.2 mg and clonidine 75µg. The women in the ITM group received oral paracetamol 1330 mg and diclofenac 50 mg, both three times daily started on the day of surgery. Oxycodone 10-20 mg twice daily was added on the first postoperative day.
Surgical and medical procedures
Deviation from normal postoperative cause
32.5%
13/40 • Number of events 13
20.0%
8/40 • Number of events 8
Surgical and medical procedures
Pharmacological treatment
15.0%
6/40 • Number of events 6
15.0%
6/40 • Number of events 6

Additional Information

Dr Lena Nilsson

Dept of anaesthesia, Linköping University Hospital, Sweden

Phone: 0046101030000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place